Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» peripheral T-cell lymphoma
peripheral T-cell lymphoma
Viracta lays off 23% of staff, pauses program to slim down for race to finish line in lymphoma
Fierce Biotech
Wed, 08/14/24 - 11:18 am
Viracta Therapeutics
layoffs
solid tumors
valganciclovir
peripheral T-cell lymphoma
Seattle Genetics' Adcetris Has Potential to Change Treatment for T-Cell Lymphoma
BioSpace
Mon, 10/8/18 - 11:36 pm
Seattle Genetics
Takeda
Adcetris
peripheral T-cell lymphoma
FDA approves Spectrum Pharma's blood cancer drug
Yahoo/Reuters
Thu, 07/3/14 - 11:26 am
FDA
Spectrum Pharmaceuticals
Beleodaq
peripheral T-cell lymphoma
Five More Years of Patent Protection, and Revenue, for Spectrum Pharmaceuticals
Yahoo/Reuters
Mon, 10/8/12 - 10:53 am
patents
Spectrum Pharmaceuticals
Folotyn
peripheral T-cell lymphoma
Spectrum Pharmaceuticals Trying to Put the Cat Back in the Bag
Motley Fool
Wed, 09/26/12 - 12:07 pm
Spectrum Pharmaceuticals
TopoTarget
belinostat
peripheral T-cell lymphoma
Spectrum Pharma Not Ready to Call Lymphoma Study a Win
TheStreet.com
Mon, 09/24/12 - 10:30 am
Spectrum Pharmaceuticals
lymphoma
belinostat
TopoTarget
peripheral T-cell lymphoma
